| Name | Title | Contact Details |
|---|
Orion Health is a global, award-winning provider of health information technology, advancing population health and precision medicine solutions for the delivery of care across the entire health ecosystem. Founded in 1993, Orion Health`s focus for 28 years has been on delivering software, services and support for healthcare organisations that empower clinicians and caregivers with the right information to deliver the best possible care. We specialise in open technology systems that seamlessly integrate all forms of health and personal data across the entire health community and present that data back to users in real-time to provide optimum patient care. We believe that software needs to do more than serve up data; it needs to provide insights in real-time to the people who need it when they need it. We provide a smart suite of solutions that enable clinicians to extract meaningful insights and make more accurate decisions about patient care. Delivering patient-centred healthcare and quality health outcomes that help patients live a healthier life. Orion Health employs 500+ people in 20 offices across 13 countries. Our technology is used by hundreds of thousands of clinicians worldwide to manage the health care of more than 100 million patients. With the most widely deployed population health management platform globally; more than 55 large-scale (regional and country-wide) solutions successfully deployed in over 15 countries, we provide the world`s number one health information platform.
This is why Family Health Care offers Respite Care. Our specially trained volunteers can step in and be there for your loved one, and give you precious time to care for yourself.
We’re creative and passionate professionals on a mission – to deliver top-notch natural health products to a global community. 🍃💪
Sunrise Dental Lab is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.